Bakay R A, Boyer K L, Freed C R, Ansari A A
Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA.
Cell Transplant. 1998 Mar-Apr;7(2):109-20. doi: 10.1177/096368979800700206.
Allogeneic transplantation for the therapy of human Parkinson's disease is being considered as a viable approach at several clinical centers worldwide. As an attempt to understand the basic biology of central nervous system (CNS) transplantation, our laboratory has developed an experimental nonhuman primate model for human Parkinson's disease and carried out preliminary studies directed at evaluating the potential pathology at the graft site. In addition, studies have been conducted to examine whether such transplantation procedures lead to specific and/or nonspecific immunologic sensitization of the host or results in generalized immunosuppression. Groups of rhesus macaques (Macaca mulatta) were either controls operated (n = 6), autografted with adrenal medullary and peripheral nerve tissue (n = 3), or allografted with fetal mesencephalic tissue (n = 6). Immunohistological studies demonstrated the presence of mononuclear cell infiltrates as early as 1 wk and up to 1 yr postoperatively, although the frequency of the infiltrating cells declined with time. The infiltrates consisted of variable numbers of cells which express CD2+, CD3+, CD4+, CD8+, CD19+, CD22+, CD25+, and CD68+. There appeared to be no difference in the frequency, kinetics, or phenotype of the infiltrating cells in operative controls compared with recipients of auto- or allografts. Tissue sections obtained postoperatively showed low levels of major histocompatibility complex (MHC) Class I antigens and no detectable level of MHC-Class II antigens in neural tissue. A small aliquot of tissue from the operative site was placed in vitro with media containing interleukin-2 (IL-2), which led to the exudation and growth of mononuclear cells that were predominantly CD4+ cells. Phenotypic studies of peripheral blood mononuclear cells (PBMC) from operative controls, auto- and allograft recipient monkeys performed at varying time periods postoperatively failed to show differences in the frequencies of subsets of T-cells, B-cells, NK-cells, or monocytes. Studies on aliquots of the same PBMC failed to show major functional differences in NK-cells, LAK cells, or response to polyclonal mitogens. Finally, recipients of allogeneic mesencephalic grafts failed to show evidence of donor-specific humoral or cellular sensitization. These data indicate that transplantation of autograft adrenal or allograft fetal mesencephalic tissues in the CNS of nonhuman primate did not induce detectable donor-specific sensitization nor nonspecific immunosuppression.
全世界有几个临床中心正在考虑将异体移植用于治疗人类帕金森病,认为这是一种可行的方法。为了试图了解中枢神经系统(CNS)移植的基础生物学,我们实验室建立了一个人类帕金森病的实验性非人灵长类动物模型,并开展了初步研究,旨在评估移植部位潜在的病理学变化。此外,还进行了研究,以检验这种移植程序是否会导致宿主发生特异性和/或非特异性免疫致敏,或者是否会导致全身性免疫抑制。将恒河猴(猕猴)分为几组,分别为手术对照组(n = 6)、自体移植肾上腺髓质和周围神经组织组(n = 3)或同种异体移植胎儿中脑组织组(n = 6)。免疫组织学研究表明,术后最早1周直至1年都存在单核细胞浸润,尽管浸润细胞的频率随时间下降。浸润细胞由数量不等的表达CD2+、CD3+、CD4+、CD8+、CD19+、CD22+、CD25+和CD68+的细胞组成。与自体移植或同种异体移植受体相比,手术对照组浸润细胞的频率、动力学或表型似乎没有差异。术后获得的组织切片显示神经组织中主要组织相容性复合体(MHC)I类抗原水平较低,未检测到MHC II类抗原水平。将手术部位的一小份组织置于含有白细胞介素-2(IL-2)的培养基中进行体外培养,导致主要为CD4+细胞的单核细胞渗出和生长。对手术对照组、自体移植和同种异体移植受体猴在术后不同时间段采集的外周血单核细胞(PBMC)进行表型研究,结果显示T细胞、B细胞、NK细胞或单核细胞亚群的频率没有差异。对相同PBMC的几份样本进行研究,结果显示NK细胞、LAK细胞或对多克隆有丝分裂原的反应没有主要功能差异。最后,同种异体中脑移植受体未显示出供体特异性体液或细胞致敏的证据。这些数据表明,在非人灵长类动物的中枢神经系统中移植自体肾上腺或同种异体胎儿中脑组织不会诱导可检测到的供体特异性致敏,也不会导致非特异性免疫抑制。